ANDA 87787, held by Abraxis Pharm. Potassium Chloride.
As of Nov 15, 2026, ANDA 87787 (Potassium Chloride), held by Abraxis Pharm, was first approved by FDA on Aug 31, 1994, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Potassium Chloride2MEQ/ML ยท injectable;injection | Potassium Chloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
